Abstract

Objective: The most common malignancy in women is breast cancer worldwide. Previous studies performed in different populations have suggested an association between Multi-Drug Resistance (MDR1) gene polymorphisms and breast cancer risk in women. The purpose of the current study is to examine relationship between MDR1 polymorphisms (C3435T, G2677T/A, C1236T, A2956G) and the risk of breast cancer in Turkish women.Methods: In this study 35 breast cancer cases and 20 healthy controls were enrolled. Identification of MDR1 genotypes was performed with the polymerase chain reaction/restriction fragment length polymorphism (PCR-RFLP) technique.Results: We observed significant difference in distribution of C3435T genotypes between the cases and the controls (cases, CC 37.1%, CT 28.6%, and TT 34.3%; controls, CC 25%, CT 65%, and TT 10%, p: 0.023). On the other hand, no significant differences in genotype and allele frequencies of C1236T and G2677T/A polymorphisms were observed between groups. We also found that all subjects carry AA genotype for A2956G polymorphism. Conclusion: Although our study group is small, the results suggest that the MDR1 C3435T polymorphism may increase the breast cancer risk in Turkish women.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call